Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-022204
Filing Date
2021-09-08
Accepted
2021-09-08 16:06:33
Documents
78
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1683414
2 ex31-1.htm EX-31.1 10956
3 ex32-1.htm EX-32.1 5095
  Complete submission text file 0001493152-21-022204.txt   8660334

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nphc-20201231.xml EX-101.INS 1238236
5 XBRL SCHEMA FILE nphc-20201231.xsd EX-101.SCH 65087
6 XBRL CALCULATION FILE nphc-20201231_cal.xml EX-101.CAL 82845
7 XBRL DEFINITION FILE nphc-20201231_def.xml EX-101.DEF 291804
8 XBRL LABEL FILE nphc-20201231_lab.xml EX-101.LAB 474473
9 XBRL PRESENTATION FILE nphc-20201231_pre.xml EX-101.PRE 401746
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32141 | Film No.: 211242212
SIC: 2833 Medicinal Chemicals & Botanical Products